7WC5
Crystal structure of serotonin 2A receptor in complex with psilocin
7WC5 の概要
エントリーDOI | 10.2210/pdb7wc5/pdb |
分子名称 | 5-hydroxytryptamine receptor 2A, MAGNESIUM ION, CHOLESTEROL, ... (5 entities in total) |
機能のキーワード | serotonin 2a receptor, psilocin, psilocybin, 5-ht, membrane protein |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 44127.76 |
構造登録者 | |
主引用文献 | Cao, D.,Yu, J.,Wang, H.,Luo, Z.,Liu, X.,He, L.,Qi, J.,Fan, L.,Tang, L.,Chen, Z.,Li, J.,Cheng, J.,Wang, S. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science, 375:403-411, 2022 Cited by PubMed Abstract: Drugs that target the human serotonin 2A receptor (5-HTR) are used to treat neuropsychiatric diseases; however, many have hallucinogenic effects, hampering their use. Here, we present structures of 5-HTR complexed with the psychedelic drugs psilocin (the active metabolite of psilocybin) and d-lysergic acid diethylamide (LSD), as well as the endogenous neurotransmitter serotonin and the nonhallucinogenic psychedelic analog lisuride. Serotonin and psilocin display a second binding mode in addition to the canonical mode, which enabled the design of the psychedelic IHCH-7113 (a substructure of antipsychotic lumateperone) and several 5-HTR β-arrestin-biased agonists that displayed antidepressant-like activity in mice but without hallucinogenic effects. The 5-HTR complex structures presented herein and the resulting insights provide a solid foundation for the structure-based design of safe and effective nonhallucinogenic psychedelic analogs with therapeutic effects. PubMed: 35084960DOI: 10.1126/science.abl8615 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (3.2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
